发明名称 |
MiR-33 inhibitors and uses thereof to decrease inflammation |
摘要 |
The inhibition of miRNA miR-33 is shown to promote the polarization of macrophages from an M1 to an M2 phenotype. MiR-33 inhibitors are therefore useful for treating inflammation in subjects. Endogenous microRNAs can be silenced using antagomirs. The miR-33 inhibitor is preferably an antagomir having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions. |
申请公布号 |
US9241950(B2) |
申请公布日期 |
2016.01.26 |
申请号 |
US201214114471 |
申请日期 |
2012.04.30 |
申请人 |
New York University |
发明人 |
Moore Kathryn J.;Rayner Katey J.;Sheedy Frederick;Fernandez-Hernando Carlos;Suarez Yajaira |
分类号 |
A61K48/00;C07H21/02;C07H21/04;A61K31/713;A61K31/712;C12N15/113 |
主分类号 |
A61K48/00 |
代理机构 |
Pabst Patent Group LLP |
代理人 |
Pabst Patent Group LLP |
主权项 |
1. A method for reducing inflammation comprising administering to a subject with an inflamed tissue comprising M1 macrophages, an inhibitor that specifically targets miR-33 in an amount effective to reduce inflammation in the tissue of the subject. |
地址 |
New York NY US |